Ex-Ante Analysis of the Costs and Benefits of Legalizing Cannabis Markets in the Czech Republic
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11220%2F25%3A10497424" target="_blank" >RIV/00216208:11220/25:10497424 - isvavai.cz</a>
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=mDpyxbrfCL" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=mDpyxbrfCL</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1017/bca.2024.45" target="_blank" >10.1017/bca.2024.45</a>
Alternative languages
Result language
angličtina
Original language name
Ex-Ante Analysis of the Costs and Benefits of Legalizing Cannabis Markets in the Czech Republic
Original language description
Cannabis is the most commonly used illicit drug worldwide. In countries with repressive drug policies, the costs of its prohibition plausibly outweigh the benefits. We conduct a cost-benefit analysis of cannabis legalization and regulation in the Czech Republic, taking into consideration alternative scenarios designed using parameters from the known effects of cannabis legalization in selected U.S. states, Canada, and Uruguay. Our analysis focuses on tax revenues, law enforcement costs, the cost of treatment and harm reduction, and the value of Quality Adjusted Life Years (QALYs). Under all the projected scenarios, the identified benefits of legalizing cannabis for personal use exceed the potential costs. The estimated net social benefit of legalization is in the range of 34.4 to 107.6 million EUR per year (or between 3.2 and 10.1 EUR per capita), depending on the size of the cannabis market and the development of cannabis prices after legalization.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
50501 - Law
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Benefit-Cost Analysis
ISSN
2194-5888
e-ISSN
2152-2812
Volume of the periodical
2025
Issue of the periodical within the volume
Neuveden
Country of publishing house
US - UNITED STATES
Number of pages
27
Pages from-to
1-27
UT code for WoS article
001454111300001
EID of the result in the Scopus database
2-s2.0-105001869700